Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to David T. Rubin

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Rubin, David T.

PropertyValue
overview Dr. David T. Rubin is Chief of the Section of Gastroenterology, Hepatology & Nutrition and the Co-Director of the Digestive Diseases Center at The University of Chicago Medicine. Dr. Rubin earned a medical degree with honors at The University of Chicago Pritzker School of Medicine. He completed his residency in internal medicine and fellowships in gastroenterology and clinical medical ethics at the University of Chicago, where he served as Chief Resident and Chief Fellow. Prior to his current appointments, Dr. Rubin served for 11 years as Director of the Gastroenterology, Hepatology and Nutrition fellowship program. He also currently serves as an associate faculty member at the MacLean Center for Clinical Medical Ethics and an associate investigator at the University of Chicago Comprehensive Cancer Center. Dr. Rubin is a Fellow of the American Gastroenterological Association (AGA), the American College of Gastroenterology (ACG), the American Society for Gastrointestinal Endoscopy (ASGE) and the American College of Physicians (ACP) and an active national member of the Crohn’s & Colitis Foundation (CCF), and is on the Board of Trustees for the ACG. Among numerous awards and honors, Dr. Rubin was chosen by his peers as a member of Best Doctors (recognized for superior clinical ability) and America’s Top Physicians (gastroenterology). Additionally, he twice received the ACG’s Governor’s Award of Excellence in Clinical Research (2003 and 2013), the Cancer Research Foundation Young Investigator’s Award (2004), and the UC Postgraduate Teaching Award in recognition of significant contributions for fellowship education (2006). In 2012, he received the CCF Rosenthal Award, a national leadership award bestowed upon a volunteer who has contributed in an indisputable way to the quality of life of patients and families. He is currently the Chair-elect of the National Scientific Advisory Committee of the CCF. He is an Associate Editor of the journal Gastroenterology and Co-Editor of the ACG On-Line Educational Universe. Dr. Rubin is the editor of a best-selling book on inflammatory bowel disease (IBD), now in its 3rd edition, and an author or coauthor of many peer-reviewed articles on treatment and management of IBD, cancer in IBD and novel paradigms, as well as the first author of the in progress ACG Guidelines for ulcerative colitis. His current research is in the area of progressive complications from uncontrolled inflammation, the doctor-patient relationship in IBD, and a variety of collaborative studies related to the microbiome and intestinal disease. He is also a featured media contact for issues related to IBD, appearing on satellite radio, television, print media and maintains a popular twitter feed @IBDMD (>9500 followers). His principal research interests include novel IBD therapies and outcomes, colon cancer prevention, and clinical medical ethics.

One or more keywords matched the following items that are connected to Rubin, David T.

Item TypeName
Concept Extravasation of Diagnostic and Therapeutic Materials
Concept Treatment Refusal
Concept Treatment Outcome
Concept Therapeutic Human Experimentation
Concept Treatment Failure
Academic Article Ethics of a paired-kidney-exchange program.
Academic Article Treatment of anal fissures with topical nitroglycerin.
Academic Article The challenge of compliance and persistence: focus on ulcerative colitis.
Academic Article Maximizing patient adherence and clinical outcomes with mesalamine in mildly-to-moderately active ulcerative colitis.
Academic Article Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab.
Academic Article Response to biologic therapy in Crohn's disease is improved with early treatment: an analysis of health claims data.
Academic Article Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease: results from the CHARM trial.
Academic Article Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction.
Academic Article Emerging issues in ulcerative colitis and ulcerative proctitis: individualizing treatment to maximize outcomes.
Academic Article A practical, evidence-based guide to the use of adalimumab in Crohn's disease.
Academic Article Total abdominal colectomy for refractory ulcerative colitis. Surgical treatment in evolution.
Academic Article We once were blind and now we see: is it time to treat ulcerative colitis to achieve mucosal healing?
Academic Article Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center.
Academic Article Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.
Academic Article Rifaximin Is Effective for the Treatment of Clostridium difficile-Associated Diarrhea: Results of an Open-Label Pilot Study.
Academic Article Will a 5-ASA a day keep the cancer (and dysplasia) away?
Academic Article Inflammation's role in rectal cancer following prostate radiotherapy, and emerging evidence for a protective role for balsalazide.
Academic Article Role of antibiotics in the management of inflammatory bowel disease: a review.
Academic Article Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
Academic Article Long-term treatment of patients with a history of ulcerative colitis who develop gastritis and pan-enteritis after colectomy.
Academic Article Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center.
Academic Article Patchy colitis and interstitial lung disease.
Academic Article Optimal doses of methotrexate combined with anti-TNF therapy to maintain clinical remission in inflammatory bowel disease.
Academic Article Therapeutic Drug Monitoring of Anti-tumor Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases.
Academic Article Successful Treatment of Ulcerative Colitis With Vedolizumab in a Patient With an Infliximab-Associated Psoriasiform Rash.
Academic Article Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
Academic Article Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis.
Academic Article Vedolizumab in the treatment of Crohn's disease.
Academic Article Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease.
Academic Article Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.
Academic Article Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial.
Academic Article Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease.
Academic Article Long-term Efficacy of Vedolizumab for Ulcerative Colitis.
Academic Article Long-term Efficacy of Vedolizumab for Crohn's Disease.
Academic Article Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases.
Academic Article Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists.
Academic Article The Impact of Therapeutic Antibodies on the Management of Digestive Diseases: History, Current Practice, and Future Directions.
Academic Article Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
Academic Article Pulmonary Eosinophilia Following Infliximab Treatment for Crohn's Disease.
Academic Article Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
Academic Article Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease.
Academic Article Methotrexate for the Treatment of Pediatric Crohn's Disease: A Systematic Review and Meta-analysis.
Academic Article Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease.
Academic Article Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
Academic Article Incidence of Arthritis/Arthralgia in Inflammatory Bowel Disease with Long-term Vedolizumab Treatment: Post Hoc Analyses of the GEMINI Trials.
Academic Article Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel Diseases.
Academic Article Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
Academic Article Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease.
Academic Article The use of tofacitinib in the treatment of inflammatory bowel disease.
Academic Article Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated Neoplasia.
Academic Article Real-World Experience with Tofacitinib in IBD at a Tertiary Center.
Academic Article Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing--ASCEND I and II combined analysis.
Academic Article Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease.
Academic Article Abnormal Pouchogram Predicts Pouch Failure Even in Asymptomatic Patients.
Academic Article Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases.
Academic Article Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe.
Academic Article Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission.
Academic Article Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis.
Academic Article Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development.
Academic Article Patient and physician preferences for ulcerative colitis treatments in the United States.
Academic Article Treatment De-Escalation in Patients With Inflammatory Bowel Disease.
Academic Article Use of Tofacitinib for the Treatment of Arthritis Associated With Ulcerative Colitis.
Academic Article Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitis.
Academic Article Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease.
Academic Article Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature.
Academic Article Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate.
Academic Article Efficacy of biosimilar infliximab CT-P13 among inpatients with severe steroid-refractory colitis.
Academic Article Diagnostic Accuracy of Fecal Calprotectin Concentration in Evaluating Therapeutic Outcomes of Patients With Ulcerative Colitis.
Academic Article Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis.
Academic Article Emerging treatment options for extraintestinal manifestations in IBD.
Academic Article Long-term safety of vedolizumab for inflammatory bowel disease.
Academic Article Cost-Effectiveness of 5-Aminosalicylate Therapy in Combination With Biologics or Tofacitinib in the Treatment of Ulcerative Colitis.
Academic Article Cost-effectiveness analysis of a fecal microbiota transplant center for treating recurrent C.difficile infection.
Academic Article Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry.
Academic Article Effective Treatment of Acute Severe Ulcerative Colitis in Pregnancy Is Associated With Good Maternal and Fetal Outcomes.
Academic Article Pouchitis in inflammatory bowel disease: a review of diagnosis, prognosis, and treatment.
Academic Article STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
Academic Article Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.
Academic Article Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium.
Academic Article Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib.
Academic Article A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab.
Academic Article Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.
Academic Article Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD.
Academic Article Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data from a Large Tertiary Center.

Search Criteria
  • Therapeutics